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Abstract
Trafficking of lung dendritic cells (DCs) to the draining lymph node (dLN) is a crucial step for the initiation of T cell responses
upon pathogen challenge. However, little is known about the factors that regulate lung DC migration to the dLN. In this
study, using a model of influenza infection, we demonstrate that complement component C3 is critically required for
efficient emigration of DCs from the lung to the dLN. C3 deficiency affect lung DC-mediated viral antigen transport to the
dLN, resulting in severely compromised priming of virus-specific T cell responses. Consequently, C3-deficient mice lack
effector T cell response in the lungs that affected viral clearance and survival. We further show that direct signaling by C3a
and C5a through C3aR and C5aR respectively expressed on lung DCs is required for their efficient trafficking. However,
among lung DCs, only CD103+ DCs make a significant contribution to lung C5a levels and exclusively produce high levels of
C3 and C5 during influenza infection. Collectively, our findings show that complement has a profound impact on immune
regulation by controlling tissue DC trafficking and highlights a potential utility for complement as an adjuvant in novel
vaccine strategies.
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Introduction
Influenza is a global health problem and current vaccination
strategies are still inadequate at providing protection against
seasonal and epidemic outbreaks [1]. Vaccination strategies
aiming to induce a protective CD8+ T cell response hold
tremendous potential, since CD8+ T cells are able to recognize
core epitopes conserved across a wide range of influenza strains
[2,3]. Hence, there is a pressing need to improve our understand-
ing on the mechanisms that contribute to the orchestration of
CD8+ T cell responses during influenza infection.
Influenza-specific T cell responses are initiated and maintained
by lung dendritic cells (DCs) which are strategically localized
within the respiratory tract to mediate this process effectively [4,5].
DCs comprise a heterogeneous population of antigen sensing and
presenting cells that control the initiation of T cell responses thus
bridging innate and adaptive immune responses [6]. Different
subsets of DCs with unique homeostasis and immune functions
had been described in both lymphoid and non-lymphoid tissues
[7]. In this regard, lung resident DCs can be divided into
CD103+CD11b2 (CD103+ DCs) and CD1032CD11b+ (CD11b+
DCs) based on the expression of the integrins aEb7 (CD103) and
ITGAM (CD11b) respectively [8,9]. During influenza infection,
both types of lung resident DCs migrate to the dLN to prime T
cells [10] henceforth referred to as migratory DC subsets (mDCs).
The complement system is an essential component of the innate
immune network and has evolved as an important bridge between
innate and adaptive immune systems, similarly to DCs, but at the
molecular level [11,12,13,14]. In particular, complement compo-
nent C3 has been shown to impact antiviral T cell immunity and
allograft rejection in a mechanism independent of intrinsic C3
expression in T cells [15,16,17,18]. These observations suggested
the involvement of an additional cell type expressing C3 that
control T cell activation. Recent studies using bone marrow
derived DCs have revealed that C3 is essential for DCs to
efficiently stimulate T cells [19,20], suggesting that DCs mediate
these aforementioned complement effects [15,16,17] on T cells by
acting both as complement producing and sensing cells. However,
the in vivo functional relevance of C3 in peripheral tissue DCs,
which play a central role in the induction of immunity by virtue of
their location [21], remains largely unexplored, necessitating
further studies.
Influenza infection is known to activate complement both
locally in the lung and systemically [22,23], but the biological
significance of complement activation during influenza infection
remains poorly understood. The functional importance of C3 in T
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cell immunity during influenza infection was initially demonstrated
by Kopf et al., who showed that C32/2 mice exhibited reduced T
cell response to influenza infection and attributed this to a possible
priming defect mediated by DCs [16]. Thus, we hypothesized that
C3 may be critically involved in the control of the T cell priming
function of lung mDCs during influenza infection.
In this study, we used C3-deficient (C32/2) mice to show that
C3 was critical for survival during influenza infection, and C3
deficiency was associated with attenuated T cell priming in the
dLN and reduced development of effector T cell responses in the
lung as previously shown [16]. However, we found that this
defective priming was not due to altered priming ability of C3-
deficient DCs but rather due to a defect of mDC migration from
the lung to the dLN in C32/2 mice. We further demonstrated that
the direct interaction of complement activation products C3a and
C5a with their receptors expressed on the surface of mDCs was
critical for their migration. Finally, we identified CD103+ DCs as
the sole mDC subset capable of secreting C3 and C5 and one of
the major source of lung C5a during influenza infection.
Altogether, our results establish a previously unidentified role for
complement activation products C3a and C5a in mediating
migratory function of mDCs and highlight the crucial role of
CD103+ DC subset as an unique complement sensing and
producing DC population controlling its own migration and the
migration of CD11b+ DCs.
Results
Complement component C3 is critical for survival during
influenza infection
C3 has been shown to be important for eliciting T cell responses
and viral clearance during influenza infection in mice [16],
although the impact of C3 deficiency on survival after influenza
infection was not well reported. In order to evaluate this, we
infected WT and C32/2 mice with a sub-lethal dose (optimized in
WT mice, 15 PFU for female and 25 PFU for male) of influenza
virus and monitored their weight loss and survival. WT mice
showed ,20% weight loss at the peak of infection and recovered
with 20% mortality as previously reported [24]. In stark contrast,
C32/2 mice showed greater weight loss on days 5 and 7, and
resulted in 100% mortality by day 12 (Fig. 1A and B). Subsequent
evaluation of effector T cell responses and viral load in the lungs
recapitulated previous observations [16], showing decreased
effector T cell responses and viral clearance in the C32/2 mice
(Fig. S1).
Absence of C3 in T cells does not directly alter their function
[16], hence we reasoned that these defects in T cell responses were
mediated by the lack of C3 in DCs, as suggested in previous
reports [19,20]. In order to investigate whether priming of
antigen-specific T cells in the dLN in response to influenza
infection was altered in C32/2 mice, we adoptively transferred
CFSE labeled OT-I CD8+ transgenic T cells into mice prior to
infection with either wild type PR8 influenza virus or recombinant
PR8 influenza virus containing the OVA epitope SIINFEKL
(PR8-OT-I). We then harvested lung dLNs at indicated time
points post-infection to assess proliferation by CFSE dilution on
SIINFEKL-Kb tetramer positive CD8+ T cells. As expected,
proliferation was observed only when mice were inoculated with
PR8-OT-I, and no proliferation was observed with PR8 influenza
virus alone, reflecting the specificity of the response (Fig. 1C).
Strikingly, the level of proliferation was significantly reduced in the
C32/2 mice in comparison with WT mice (Fig. 1C). CD4+ T cell
priming in the dLN was also evaluated using OT-II (CD4)
transgenic T cells and PR8 influenza virus containing the OVA
epitope ISQAVHAAHAEINEAGR (PR8-OT-II). Similarly, we
found that the priming of CD4+ T cells was significantly reduced
in the C32/2 mice when compared to WT controls (Fig. 1D).
Since C3 has been reported to influence the expression of co-
stimulatory molecules on DCs [19], we tested whether diminished
levels of costimulation could explain the decreased T cell responses
by measuring the expression of costimulatory molecules on mDCs
in the dLN of both WT and C32/2 mice on day 2 post-infection.
Resident and mDC subsets in the dLN were characterized as
shown in Fig. S2. We found comparable levels of CD86 and CD40
expression, while CD80 expression was even increased in the
C32/2 mDCs (Fig. 1E and F), excluding an intrinsic maturation
defect in C32/2 DCs. Finally, to understand whether the T cell
priming defect observed in vivo was due to a decreased priming
ability by C32/2 mDCs (Fig. 1C and D), we sorted CD103+ DCs
and CD11b+ DCs on day 2 post infection with PR8-OT-I and
evaluated their priming ability ex vivo. A strong proliferation of
OT-I CD8+ T cells was observed only when CD8+ T cells were co-
cultured with CD103+ DCs, but not with CD11b+ DCs, an
observation supporting the predominant role of CD103+ DCs in
early CD8+ T cell priming [10]. However, ex vivo priming ability
was comparable between WT and C3-deficient CD103+ DCs
(Fig. 1G), demonstrating that there was no intrinsic priming defect
in C3-deficient CD103+ DCs.
C32/2 mice show defective trafficking of mDC subsets
from the lung to the dLN during influenza infection
Next, we investigated the composition of mDC subsets in the
lung and lung dLN at steady state and during the course of
influenza infection to test whether the priming defect could be
explained by a defect of the mDC network in the lung and dLN of
C32/2 mice. The gating strategy employed for characterizing
lung mDCs is shown in Fig. S3 [25,26]. Under steady state
conditions, the relative numbers of CD103+ DCs and CD11b+
DCs were comparable between C32/2 and WT mice, whereas
enumeration of absolute numbers showed a slight decrease for
CD103+ DCs only in the C32/2 mice (Fig. 2A–C). Upon
influenza infection, both the relative and absolute numbers of lung
CD103+ DCs and CD11b+ DCs became comparable between
C32/2 and WT mice during influenza infection (Fig. 2A–C).
Author Summary
Influenza is a global health problem frequented by
epidemics and pandemics. Current vaccines against
influenza offer limited protection hence the need for
reformulation and repeated vaccination. There is a
pressing need to develop newer vaccines that are able
to generate T cell response. In order to develop such
vaccines, there is a need to understand how T cell
responses are generated during influenza infection. Influ-
enza specific T cell responses are generated by the
dendritic cells (DCs) in the lung. Upon influenza infection,
DCs in the lung carry viral peptides to the draining lymph
node (dLN) to initiate an immune response. Thus,
migration of DCs from the lung to the dLN is an important
step in the initiation of influenza specific T cell response.
We now show that activation products of the complement
system interact with their receptors on the DCs, which
signals for the DCs to migrate from the lung to the dLN.
Thus, our results reveal a previously unknown function for
complement in mediating lung DC migration during
influenza infection and highlight its potential as an
adjuvant in novel vaccine strategies.
Complement Mediates Lung DC Migration
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Figure 1. C32/2 mice show greater weight loss and mortality during influenza infection. (A) Percentage of body weight loss after
influenza infection. A weight loss of ,20% and recovery represents a sub-lethal infection. (B) Survival curve comparing WT and C32/2 mice during
influenza infection (n = 6–7 in each group). (C) Plots represent ex vivo analysis of CFSE-labeled OT-I CD8+ T cell proliferation in the dLN 3 days after
infection with PR8 and PR8-OT-I (bottom). The graph on the right shows the respective division index for the proliferating OT-I CD8+ T cells for each
group of mice. (D) Plots represent ex vivo analysis of CFSE-labeled OT-II CD4+ T cell proliferation in the dLN 3 days after infection with PR8 and PR8-
OT-II (bottom). The graph on the right shows the respective division index for the proliferating OT-II CD4+ T cells for each group of mice. (E)
Histogram showing expression of costimulatory molecules CD86, CD80 and CD40 on CD103+ DCs and CD11b+ DCs in the dLN on day 2 post infection.
Filled histogram: Isotype control, dashed histogram: Naı¨ve, open histogram: infected. (F) Bar graphs show the mean fluorescent intensity (MFI) of
CD86, CD80 and CD40 expression on CD103+DC and CD11b+ DC subsets in the dLN of naı¨ve and influenza infected (Day 2) WT or C32/2 mice. (G)
Plots represent CFSE-labeled OT-I CD8+ T cell proliferation 3 days after co-culture with sorted CD103+ DCs and CD11b+ DCs obtained from pooled
dLN of PR8-OT-I influenza infected mice at a ratio of 1:10 (DC:T cells). Results shown are representative of four experiments with similar results. The
values are expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003115.g001
Complement Mediates Lung DC Migration
PLOS Pathogens | www.plospathogens.org 3 January 2013 | Volume 9 | Issue 1 | e1003115
These results show that the T cell priming deficit observed in
C32/2 mice is not due to a defect in the differentiation of lung
mDCs.
Next, we assessed whether the migration ability of lung mDCs
was compromised. Under steady state, lung mDCs constitutively
migrate at a slow rate to the dLN, a process strongly increased
under inflammatory conditions [8]. As expected, in WT mice
during the course of infection, the absolute numbers of both
CD103+ DCs and CD11b+ DCs increased in the dLN by day 1
post infection and further by day 2 post infection (Fig. 2D–F).
However, absolute numbers of both CD103+ DCs and CD11b+
DCs were significantly decreased in C32/2 mice, suggesting a
decreased migration capacity of CD103+ DCs and CD11b+ DCs
at both steady state and at all time points tested after influenza
infection (Fig. 2D–F).
To confirm these data, the migration of mDCs from the lung
to the dLN was tracked using CFSE delivered intranasally
into the lungs at different time points after influenza infection
[27]. As expected, the relative numbers of CFSE+ mDCs in the
dLN increased after influenza infection, reaching a maximum
by day 3 in the WT mice. However, CFSE+ mDC accumu-
lation (independent of subsets) was significantly reduced in the
C32/2 dLN (Fig. 3A left panel and B). Upon enumeration of
CD103+ DCs and CD11b+ DCs within the CFSE+ mDC
population, we found that migration of both CD103+ DCs and
CD11b+ DCs was severely compromised in the C32/2 mice
(Fig. 3A, C and D). In order to understand whether a strong
inflammatory signal is able to overcome the defective signaling
on mDCs due to the lack of C3, we administered LPS
intratracheally shortly after influenza infection and then
evaluated mDC migration in C32/2 mice. Our observations
indicated that LPS administration was not able to overcome
the defective trafficking of both subset of lung mDCs in the
C32/2 mice, although a mild effect was observed for CD11b+
DCs (Fig. 3E). These observations indicate that the critical
importance of complement mediated signaling in lung mDC
trafficking is independent of inflammatory signals. Altogether,
our observations demonstrate that migration of C32/2 mDCs
to the dLN is significantly reduced compared to WT during
inflammation.
Figure 2. Migratory DC subsets are reduced in the dLN in C32/2 mice after influenza infection. (A) Kinetics of CD103+ DCs and CD11b+
DCs in the lungs during influenza infection in WT and C32/2 mice. Populations were gated as show in Fig. S2. Numbers within the dot plot represent
average percentage of cells for the group. (B and C) Absolute numbers of CD103+ DC (B) and CD11b+ DC (C) subsets in lungs during steady state and
during influenza infection. (D) Kinetics of CD103+ DCs and CD11b+ DCs in the dLN during influenza infection in WT and C32/2 mice. Populations were
gated as shown in Fig. S1. Numbers within the dot plot represent average percentage of cells for the group. (E and F) Absolute numbers of CD103+
DC (E) and CD11b+ DC (F) subsets in dLN during steady state and during influenza infection. The values are expressed as mean 6 SEM. The data are
representative of three different experiments with similar results. *, P,0.05, and **P,0.01.
doi:10.1371/journal.ppat.1003115.g002
Complement Mediates Lung DC Migration
PLOS Pathogens | www.plospathogens.org 4 January 2013 | Volume 9 | Issue 1 | e1003115
Viral uptake and maturation is not affected in mDCs from
C32/2 mice
Complement component C3 mediated opsonization has
been shown to affect viral uptake by DCs [28]. To test whether
reduced viral uptake by C32/2 DCs could explain the
defective mDCs migration in C32/2 mice, we examined their
antigen uptake capacity using DiD labeled influenza virus as
previously described [25]. We first infected mice with
unlabelled PR8 influenza virus to establish an infection and
its associated inflammation, and subsequently inoculated the
same mice with DiD labeled PR8 influenza virus 16 hours
Figure 3. Tracking of mDC migration from the lung to the dLN demonstrates defective mDC migration in C32/2 mice during
influenza infection and intratracheal administration of LPS does not recover the defective mDC migration during influenza
infection. WT and C32/2 mice were infected with influenza virus; 16 hours before sacrificing, cells in the lungs were labeled with 8 mM CFSE by
intranasal instillation. dLN was harvested and analysed for CFSE+ mDCs using gating strategy shown in Fig. S1. (A) Dot plots show CFSE+ mDCs (first
panel) in the dLN and subsequent panels show CD103+ DCs and CD11b+ DCs after gating on CFSE+ mDCs at indicated times after influenza infection.
Numbers within the dot plot represent cell number. (B) Kinetics of frequency of CFSE+ mDCs in the dLN of influenza infected mice. Absolute number
of CFSE+ CD103+ DCs (C) and CFSE+ CD11b+ DCs (D) in the dLN at indicated time points after influenza infection. LPS (2 mg in PBS) was administered
intratracheally after 6 hours to either uninfected or flu infected C32/2 mice and the migration of mDCs from the lung to the dLN were followed as
described earlier using CFSE on day 2 post infection. (E) Number of CFSE+ CD103+ (left) and CD11b+ (right) DCs in LPS administered C32/2 mice in
comparison with WT mice without LPS administration. The values are expressed as mean 6 SEM. The data are representative of three different
experiments with similar results. *, P,0.05, ** P,0.01 and *** P,0.001.
doi:10.1371/journal.ppat.1003115.g003
Complement Mediates Lung DC Migration
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Figure 4. C32/2 mDCs display similar capacity for virus uptake and maturation. (A) Dot plots show the percentage of DiD flu+ uptake by
CD103+ DC (left panel) and CD11b+ DC (right panel) in WT and C32/2 mice 16 hrs after DiD flu administration on day 1 post infection with PR8. (B)
Bar graph shows the average numbers of DiD flu+ CD103+ DCs and DiD flu+ CD11b+ DCs in the lungs of WT and C32/2 mice. (C)Single cell
preparations from the lungs were enriched for DCs by a density gradient method. Enriched DCs were infected with influenza virus under ex vivo
culture conditions and six hours later the CD103+ and CD11b+ DCs were flow sorted. Q-RT-PCR for the indicated cytokines were performed on the
RNA obtained from the CD103+ and CD11b+ DC populations. Bar graph shows % relative expression in comparison to un-infected control. (D) WT and
C32/2 mice were infected with flu and 24 hours later the CD103+ and CD11b+ DCs from the lungs were flow sorted. Q-RT-PCR for the indicated
cytokines were performed on the RNA obtained from the CD103+ and CD11b+ DC populations. Bar graph shows % relative expression in comparison
to un-infected control. (E) Bar graphs shows the mean fluorescent intensity of CD86, CD40 and CD80 expression on CD103+DC and CD11b+ DC
subsets in the lungs of naı¨ve and PR8 infected WT or C32/2 mice. The data are representative of three different experiments with similar results. The
values are expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003115.g004
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before harvesting the lungs. DiD+ mDC subsets were compa-
rable between C32/2 and WT mice suggesting that the lack of
C3 did not affect antigen uptake (Fig. 4A and B).
Migratory DCs upon exposure to antigen under inflammatory
conditions undergo maturation before migrating to the dLN and
C3 is known to influence the expression of costimulatory molecules
[29]. In order to understand whether the mDCs in the C32/2
mice produced sufficient inflammatory mediators comparable to
the WT mice, we examined the expression levels of inflammatory
cytokines in the mDCs after ex vivo and in vivo influenza infection.
Expression levels of IL-1b and IL-6 were comparable in the mDCs
under both ex vivo and in vivo conditions. However IL-12p40
expression were higher in the C32/2 mice when mDCs were
infected under ex vivo conditions whereas comparable under in vivo
conditions. (Fig. 4C and D). Subsequently, we evaluated the
maturation of mDC subsets by analyzing the expression of co-
stimulatory molecules after influenza infection (Fig. 4E). Expres-
sion levels of CD86, CD80 and CD40 on mDCs were comparable
between C32/2 and WT mice during the course of infection.
CCR7 expression on mDCs has been shown to be important
for their migration to dLN [29,30,31], hence we evaluated the
expression of CCR7+ at the surface of lung mDCs. Under
steady state, the frequency of CCR7 expressing mDCs was
lower in C32/2 mice (Fig. 5A–C). After influenza infection,
the relative numbers of CCR7 expressing mDCs increased in
both groups to a similar extent. However due to the reduced
initial frequency of CCR7+ mDCs in C32/2 mice at steady
state, the proportion of CCR7+ mDCs upon flu infection
remained lower than WT (Fig. 5A–C). These observations
suggest that lack of C3 did not affect the up- regulation of
CCR7 expression on mDCs under inflammatory conditions.
Altogether, these results show that C3-deficient mDCs are not
defective in viral uptake and are fully competent in the expression
of inflammatory mediators and co-stimulatory molecules for T-cell
priming, but are less migratory.
Complement components C3 and C5 are produced by
CD103+ DCs upon influenza infection
The absence of C3 causes a complete block in complement
activation and hence C32/2 mice lack the ability to generate both
C3a and C5a [22]. To ascertain whether these activation products
are directly involved in mediating mDC migration, we first
quantified the levels of C3a and C5a in the bronchioalveolar
lavage fluid before and after influenza infection in WT mice by
ELISA. At steady state, C3a levels were high, further increasing by
approximately 4-fold on day 2 after infection and returning to
background level by day 4 (Fig. 6A). In the case of C5a, steady
state levels were very low, increasing by approximately 7-fold and
17-fold on days 2 and 4 respectively post infection, before
returning to background levels by day 7 post infection (Fig. 6A).
Next, we investigated the cellular source of C3a and C5a and
assessed the ability of lung mDCs to synthesize and secrete C3 and
C5 during infection. Lung DCs before and after influenza
infection were sorted and C3 and C5 mRNA expression levels
were determined by qRT-PCR. Both C3 and C5 mRNA levels
were significantly upregulated after influenza infection in CD103+
DCs; C3 levels were upregulated by approximately 3-fold on day 1
post infection and 50-fold on day 3 after infection (Fig. 6B), while
C5 levels were upregulated 2-fold on day 1 post infection and 5-
fold on day 3 (Fig. 6C). No modulation of C3 and C5 mRNA
expression was observed in CD11b+ DCs after influenza infection
(Fig. 6B and C).
Since only CD103+ DCs showed increased C3 and C5 mRNA
expression upon influenza infection, we evaluated the contribution
of CD103+ DCs to the observed increase in C3a and C5a levels in
the lung during influenza infection. For this purpose, we used
langerin-DTR mice to specifically deplete CD103+ DCs [10].
Langerin-DTR mice specifically expressed DTR on CD103+ DCs
in the lung and DT administration efficiently depleted lung
CD103+ DCs (Fig. S4), and subsequent influenza infection in DT-
treated langerin-DTR mice did not cause increased C3a and C5a
Figure 5. C32/2 mDCs show similar fold CCR7 up regulation upon influenza infection. (A) Representative FACS plots for CCR7 expression
in lung mDC subsets of naı¨ve and PR8 infected WT or C32/2 mice. Percentage CCR7 expression on CD103+ DCs (B) and CD11b+ DCs (C) during the
course of influenza infection. The values are expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003115.g005
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levels in the lungs on days 2 and 4 when compared with CD103+
DCs sufficient mice (Fig. 6D and E).
Importantly, when depletion of lung CD103+ DCs in langerin-
DTR mice was followed by infection with PR8-OT-I, priming of
OT-I CD8+ T cells in the dLN was severely reduced when
compared with PR8-OT-I infected WT (Fig. 7A), similar to our
observations in the C32/2 mice (Fig. 1C). CD103+ DCs depleted
langerin-DTR mice infected with influenza displayed greater
weight loss (Fig. 7B), higher mortality (Fig. 7C), reduced lung
effector T cell response (Fig. 7D–G) and increased viral load
(Fig. 7H) as compared to WT, paralleling our observations in
C32/2mice (Fig. 1A and B). Since DT administered langerin-
DTR mice showed rapid mortality, we evaluated whether DT
administration induced any toxicity during influenza infection in
WT mice. Our observation did not indicate any toxicity for DT in
WT mice during influenza infection (Fig. S5).
Among the mDC subsets, only the CD103+ DCs were found to
produce the complement components C3 and C5 upon influenza
infection (Fig. 6B and C) and depletion of CD103+ DCs
significantly reduced the availability of C3a and C5a in the lungs
(Fig. 6D and E). We hypothesized that CD11b+ DCs rely on
complement produced by CD103+ DCs for their migration to the
dLN. Therefore, we followed the migration of CD11b+ DCs in the
langerin-DTR mice after depleting the CD103+ DCs. Our results
suggested that depletion of CD103+ DCs in langerin-DTR mice
significantly affected the migration of CD11b+ DCs, supporting
our hypothesis (Fig. 7I and J). Altogether, these observations
suggest that C3a and C5a produced by CD103+ DCs are crucial
for their migration to the dLN in order to initiate protective T cells
responses and also control the migration of CD11b+ DCs.
Locally produced C3a and C5a provide migratory signals
by interacting with their receptors on mDCs
Our data suggest that sensing of complement activation
products C3a and C5a by mDCs is crucial for their migration to
the dLNs, which could be mediated by expression of the receptors
C3aR and C5aR on mDCs during infection. Thus, we examined
the expression of C3aR and C5aR mRNA in mDC subsets by
qRT-PCR. In CD103+ DCs, there was a slight increase in the
expression of C3aR mRNA on day1 post infection, and a 4-fold
increase by day 2 post infection. C5aR also increased by 4-fold on
day 1 and by 90-fold on day 2 post infection (Fig. 8A and B). In
CD11b+ DCs, the expression of both C3aR and C5aR was higher
even under steady state as compared to CD103+ DCs and showed
a modest increase on day 2 post infection (Fig. 8A and B).
To determine whether mDC migration to the dLNs was directly
controlled through interaction of C3a and C5a with their
receptors, we blocked C3aR and C5aR either alone or together
in vivo using specific, high affinity competitive antagonists [32,33].
Compstatin was used as the control peptide since it is known to
Figure 6. Lung C3a and C5a levels are up regulated during influenza infection by exclusive contribution from CD103+ DCs. (A) Bar
graph shows the amounts of C3a and C5a per 100 mg protein in BAL fluid from naı¨ve and PR8 infected WT mice on day 2, 4 and 7 post infection. (B
and C) Bar graphs showing the relative mRNA expression levels of C3 and C5 in FACS sorted lung CD103+ DC and CD11b+ DC subsets in naı¨ve or PR8
infected WT mice on day 1 and 3 post infection. Highest expression level in the naı¨ve mice is taken as 100%. (D and E) Bar graphs show the amount
of C3a and C5a per 100 mg protein in BAL fluid from naı¨ve and PR8 infected langerin DTR mice with or without the depletion of CD103+ DCs. The data
are representative of three different experiments with similar results. The values are expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003115.g006
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Figure 7. Langerin-DTR mice show effector T cells response and survival characteristics similar to those of C32/2 mice upon
influenza infection and has defective CD11b+ DC migration. (A) Plots represent ex vivo analysis of CFSE-labeled OT-I CD8+ T cells proliferation
in the dLN 3 days after infection with PR8 and PR8-OT-I (bottom) in WT and CD103+ DCs depleted langerin-DTR mice. (B) Percentage of body weight
loss after influenza infection. (C) Survival curve comparing WT, C32/2 and Langerin –DTR mice during influenza infection (n = 6 per group). (D) Graph
shows the relative mRNA expression level of influenza M protein in lung tissues of WT and CD103+ DCs depleted langerin-DTR mice infected with
4 PFU of PR8. (E) Graph shows the frequency of IFNc secreting CD4+ T cells in lungs by ex vivo overnight stimulation with MHC-II flu peptide on day 7
post infection. (F) Bar graph shows the absolute numbers of IFNc secreting CD4+ T cells in lungs on day 7 post infection (G) Graph shows the
frequency of Flu specific CTL response in lung as measured by Flu peptide (ASNENMETM (NP 366–374)/H-2D
b tetramer staining on day 7 post infection.
(H) Bar graph shows the absolute numbers of flu specific CD8+ T cells in lungs by tetramer staining on day 7 post infection. DT treated WT and
Langerin-DTR mice were flu infected and the migration of CD103+ and CD11b+ DCs were evaluated as described before on day 3 post infection. (I)
Dot plots show CD103+ and CD11b+ DCs mDCs in the dLN of DT treated and untreated WT and Langerin-DTR mice. Numbers within the dot plot
represent cell number. (J) Total number of CD103+(top) and CD11b+(bottom) DCs in the dLN of flu infected mice. Results shown are representative of
at least three different experiments with similar results. The values are expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003115.g007
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Figure 8. C3aR and C5aR expression on mDCs is upregulated upon influenza infection and blockade of the receptors inhibits mDC
migration to the dLN. C3aR (A) and C5aR (B) expression in FACS sorted lung CD103+ DC and CD11b+ DC subsets in naı¨ve or PR8 infected WT mice
on day 1 and 3 post infection. Highest expression level in a naı¨ve mouse is taken as 100%. (C and D) Tracking of mDC from the lung to the dLN (as
described in Fig. 3) in mice treated with PBS or compstatin or C3aR antagonist (C3aRA) or C5aR antagonist (C5aRA) or both C3aRA and C5aRA
together. Bar graphs show the absolute numbers of CFSE+ CD103+ DC (C) and CD11b+ DC (D) subsets in the draining lymph nodes on day 2 post
infection. The data are representative of three different experiments with similar results. The values are expressed as mean 6 SEM. (E–G) Total
CD11c+ cells were purified from the lungs WT and C3aR2/2C5aR2/2 mice that has been flu infected 18 hours before. Purified cells were CFSE labeled
and then transferred (56105 cells obtained by pooling CD11c+ cells from 5–6 mice) into a WT mice intratracheally that has been previously (36 hours
before) infected with flu. CFSE+ mDCs were analysed for the number of CD103+ and CD11b+ DCs in the dLN of recipient mice 18 hours after adoptive
transfer of cells. (E) Right panel shows the number of CD103+ and CD11b+ DCs within the CFSE+ mDC population in the dLN. Numbers indicate the
number of cells within the gate. (F) Percentage of CFSE+ mDC in the dLN gated from CD11chi MHC IIhi cells as shown in Fig. S2. (G) Bar graph showing
the number of CD103+ and CD11b+ DCs within the CFSE+ mDCs in the dLN of adoptively transferred recipient mice. The data are representative of
three different experiments with similar results.
doi:10.1371/journal.ppat.1003115.g008
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possess no complement inhibiting property in mice [33].
Treatment with antagonists started 2 days before infection and
was continued daily. CFSE instillation was done 16 hours before
sacrificing the mice. At day 2 post infection, the number of
CD103+ DCs and CD11b+ DCs were quantified within the
CFSE+ mDCs in the dLN. CD103+ DC numbers were marginally
reduced when either C3aR or C5aR was blocked but were
significantly reduced when both were blocked together (Fig. 8C). A
significant reduction in CD11b+ DC migration was observed when
C3aR was blocked alone or together with C5aR (Fig. 8D). These
results indicate that direct signaling through both complement
receptors C3aR and C5aR is critical for the migration of mDCs
from the lung to the dLNs.
To confirm that the C3aR and C5aR receptors on mDCs
directly mediate their migration rather than by the receptors on
other cells in the lungs, we purified total CD11c+ DCs from the
lungs of WT and C3aR2/2C5aR2/2 mice that had been flu
infected 18 hours before, CFSE labeled and transferred them
intratracheally to flu infected WT recipient mice. We then
determined the number of donor CD103+ DCs and CD11b+
DCs in the dLN 18 hours after adoptive transfer. We observed a
significantly reduced CD103+ DCs in the mice that received
CD11c+ DCs from C3aR2/2C5aR2/2 mice in comparison with
mice that received CD11c+ DCs from WT mice. Although the
CD11b+ DCs showed a similar trend, it is important to note that
the CD11b+ DCs have delayed migration kinetics as compared to
CD103+ DCs. These results suggest a direct role for these
receptors on these mDCs in their migration to the dLN during
influenza infection (Fig. 8E–G).
Discussion
Influenza infection is known to activate complement in the lung
with an increase in complement and complement activation
products, although the pathway through which it is activated
remains unknown [22,23]. Our study has uncovered the role of
lung resident DCs in this process and highlighted their importance
as complement producing and sensing cells. Our observations
showed that under steady state conditions, lung C3a levels are high
and are likely contributed by cells other than CD103+ DCs.
However, it is interesting to note that upon influenza infection,
CD103+ DCs exclusively produced high levels of C3 and C5,
yielding activation fragments C3a and C5a. These anaphylotoxins,
in turn, interacted with their receptors on both CD103+ DCs and
CD11b+ DCs to promote DC migration.
Furthermore, our studies using C3aRA and C5aRA demon-
strate that C3a and C5a exhibit overlapping but not fully
redundant functions because blockade of both their receptors
has a significantly more profound effect on mDC migration than
the blockade of either alone. Also adoptive transfer experiments
using both receptor (C3aR2/2C5aR2/2) deficient lung DCs
indicated that signaling mediated by both C3a and C5a on mDCs
is required for their effective migration. Our results also
highlighted the requirement of C3 in the maintenance of
CD103+ DCs under steady state. Complement is known to
regulate DC induced inhalation tolerance through C3’s opsonisa-
tion property on innocuous antigen [34]. Hence in the absence of
C3, innocuous antigens are less efficiently taken up by CD103+
DCs, decreasing their ability to migrate (our data shows decreased
number mDC in the dLN under steadystate) and thus proliferating
less under steady state. However, the requirement of C3 in the
maintenance of CD103+ DCs was limited to steady state, since
under strong inflammatory conditions, deficiency of C3 seems not
to affect CD103+ DCs number in the lung.
The specific production of C3 and C5 by CD103+ DCs
underlines their central role in transporting antigen from the lung
to the dLN, allowing the priming of T-cells during the early phase
of influenza infection [10,25]. It is also interesting to note that
CD103+ DCs control the migration of CD11b+ DCs based on the
fact that CD11b+ DCs do not produce C3and C5 upon influenza
infection, and that their migratory function is facilitated through
the production and generation of complement activation products
from CD103+ DCs. Thus, to the best of our knowledge, our data
demonstrates for the first time how one subset of DC is able to
control the functioning of another in a complement dependent
manner. Therefore, the defective priming observed in the C32/2
mice may be primarily due to a profound defect in DC-dependent
transport of viral antigen to the dLN. In addition the frequency of
resident DCs (CD8a+ DCs) in dLN were comparable between WT
and C32/2 mice (Fig. S2), ruling out their contribution to this
defect. This is further supported by our observations in CD103+
DC-depleted langerin-DTR mice which showed deleterious effects
on survival and effector T cell responses similar to those observed
in C32/2 mice upon influenza infection.
Our results also indicated that the percentage of mDCs that
express CCR7 was low under steady state in the C32/2 mice and
remained low during influenza infection despite CCR7 upregula-
tion. These results suggest that lack of complement affects CCR7
expression only under steady state, but that CCR7 upregulation
during maturation was unaffected in the absence of complement
mediated signaling (Fig. 5A–C). Although CCR7 has been shown
to be critical for mDC migration to the dLN, its upregulation
alone was insufficient to compensate for normal mDC migration,
suggesting that multiple signals control DC migration to the LNs
[35,36,37]. Supporting this view, NLRP10, a nucleotide-binding
domain leucine-rich-repeat-containing receptors (NLR) has been
recently implicated in DC migration, independently of CCR7
mediated signaling [38]. Of note, expression of factor-H and
CD59a, genes that control complement activation was found to be
altered in DCs from NLRP102/2 mice, suggesting a possible
coordination between complement and NLRP10 in facilitating
DC migration [38].
Previous studies have shown that DC-derived and -activated C3
and C5 could signal via C3aR and C5aR in an autocrine manner
to promote T-cell activation during cognate interaction [19]. In
addition, C5aR2/2 DCs exhibited attenuated proinflammatory
cytokine production, lower expression of MHC-II and costimula-
tory molecules in response to LPS challenge, as well as reduced
capacity for allospecific T-cell stimulation [39]. Similarly, C3-
deficient macrophages exhibited lower MHC-II expression and
poor ability to expand alloreactive T-cells [40]. These studies,
however, were limited by the fact that experiments were
performed under in vitro conditions and were confined to bone
marrow-derived DCs or macrophages. Furthermore, it is not
clearly well established how much these in vitro derived cells are
related to resident DCs within non-lymphoid organs. Tissue
mDCs are derived from committed circulating DC precursors
which migrate from the bone marrow to the periphery and
differentiate into distinct DC subsets [7], whereas bone-marrow
DCs were proposed to be rather of monocytic origin [41,42].
Furthermore, monocyte-derived DCs or inflammatory DCs are
absent at steady state and only appear during inflammatory
conditions, which permits their differentiation from Ly6Chi blood
monocytes [31,41]. Apart from their late appearance, these
monocyte-derived DCs possess little ability to acquire viral
particles, although their soluble protein uptake capacity is
comparable with mDCs [43]. Furthermore, we observed that C3
does not play a costimulatory role on lung mDCs as the expression
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of maturation markers (Fig. 1E,F, Fig. 4E and Fig. 5A–C) and the
priming ability of mDCs from the dLN were comparable between
WT and C32/2 mice during influenza infection (Fig. 1G).
Supporting this similarly, the expression of costimulatory mole-
cules on cDCs was not affected after infection with Listeria
monocytogenes in C32/2 mice [44], suggesting that complement
mediated signaling is dispensable for DC maturation during
infection. These results are in sharp contrast with previous
observations using bone marrow-derived DCs, stimulated with
soluble ovalbumin or LPS [19,20]. It is thus important to draw a
distinction between these two DC subtypes as it is apparent that
complement signaling may mediate different functions on these
cells. We also observed that acute administration of LPS was
unable to overcome the defective mDC migration in C32/2 mice
suggesting that complement mediated signaling operate indepen-
dently of the inflammatory signal in mediating lung mDC
trafficking during influenza infection.
CD8+ T cell responses are critical in the protection against influenza
infection [45], and it is noteworthy that C3 deficiency affects T cell
immunity, viral clearance and survival [16,22]. Early lethality in
CD103+ DC depleted langerin DTR mice paralleling C32/2 mice
though surprising, highlights the critical importance of C3 and its
contribution by CD103+ DCs in the control of early viral replication.
C32/2 mice showed increased early viral replication kinetics as
compared to WT mice (data not shown) suggesting a role for C3 in
mediating innate antiviral immunity. Thus, our observations reiterate
the critical importance of C3 during influenza infection, and we
surmise increased viral load leading to pneumonia as a possible cause of
mortality in the C32/2 mice. This is further strengthened by the report
in the recent 2009 H1N1 pandemic patients wherein individuals who
had severe disease had lower C3 levels in the serum, while the C3
concentrations were higher in moderately ill subjects [46]. These
observations clearly suggest that complement has a key role in
determining the outcome of influenza infection in both mice and
humans. Because of its crucial role in protection against influenza,
defects in many of the complement proteins, although rare, may be
associated with increased susceptibility to influenza infection. Strikingly,
deficiency or a defect in factor H and factor I are known to increase the
susceptibility to bacterial infections, due to lack of C3 regulation [47].
Similarly, deficiency of mannose-binding lectin (MBL), an activator of
complement via the lectin pathway, is more prevalent as compared to
other complement component deficiency and is known to be associated
with increased susceptibility to upper respiratory tract infections in
human and to influenza infection in mice [48,49]. Although
complement deficiency is rare in humans, genetic polymorphisms in
complement proteins such as factor I, factor B, C3 and factor H are
known to affect their availability, activity, and susceptibility to chronic
disease conditions [50,51,52,53,54,55,56]. Thus, it is possible that
complement deficiency/polymorphisms which affect the level and
functioning of C3 in an individual may be associated with higher
susceptibility to influenza infection as a consequence of compromised
DC migration, T-cell priming and decreased viral clearance resulting
in severe disease outcome. By demonstrating a novel role for C3 in
regulating tissue DC trafficking, our data may also provide a rationale
for complement to be exploited as a target for controlling tissue
immunity by modulating mDC emigration and as an adjuvant in novel
vaccine strategies for enhancing mDC migration to the lymph node to
initiate stronger T-cell responses.
Materials and Methods
Ethics statement
Experiments were performed under the approval of the
Institutional Animal Care and Use Committee in compliance
with the Law and Guidelines for Animal Experiments of the
Biological Resource Center (BRC) of Agency for Science,
Technology and Research (A*STAR), Singapore. These guidelines
were established by the national advisory committee for laboratory
animal research as per the Animals and Birds Act 2002.
Mice
C57BL/6 mice were obtained from the BRC, C32/2 C3aR2/2
and C5aR2/2 mice were purchased from The Jackson Labora-
tory. C3aR2/2 C5aR2/2 double receptor mice were generated
by crossing C3aR2/2 mice and C5aR2/2 mice. Langerin DTR,
OT-I Rag12/2 and OT-II Rag22/2 mice (Taconic) were
obtained from Mutant Mouse Collection Core Service, Singapore
Immunology Network (SIgN), Singapore. Homozygous OT-II
Rag22/2 mice were crossed once with homozygous CD45.1 mice
(Jax) and the offspring from the F1 generation, referred to
hereafter as CD45.1+OT-II, were used for adoptive transfer
studies. Experiments were generally performed with sex matched
mice at 6–10 week of age. Animals were bred under specific
pathogen-free conditions at the BRC.
Influenza virus infection
Influenza virus strain A/PR/8/34 (H1N1) was obtained from
National Institute for Medical Research (NIMR, London, UK).
Recombinant influenza A/PR/8/34 strains containing the chick-
en OVA epitope SIINFEKL (PR8 OT-I) and chicken OVA
peptide ISQAVHAAHAEINEAGR (323–339; PR8 OT-II) were a
gift of P. Thomas (St. Jude Children’s Research Hospital,
Memphis, TN). Mice were infected intranasally with one of the
influenza strains at 15 or 25 plaque forming units (PFU) in 25 ml
for female or male mice respectively. The influenza dose was
optimized to give ,20% weight loss in WT mice during the peak
of infection and recovery without incidence of mortality. In some
experiments, diphtheria toxin was administered intraperitoneally
(at 7 ng/g of mouse weight) before and/or during the course of
influenza infection for depleting langerin-expressing CD103+ DCs.
In some experiments LPS was administered intratracheally shortly
followed by influenza infection.
Flow cytometry and cell sorting
Anti-mouse Abs used for FACS analysis were CD3-APC from
BD Pharmingen; CD11c- PerCPCy5.5, MHCII-PB, CD103-PE,
CD11b-PE-Cy7, B220-APCCy7, CD4-PE, CD86- FITC, CD80-
FITC, CD40-APC and CD8-PE-Cy7 from eBioscience; Ly6G/
Ly6C-APC, CCR7-APC and IFNc-APC from Biolegend. For live
cell gating, live/dead fixable dye (Molecular Probes, Invitrogen)
was used. Lung DCs were identified as low auto fluorescent
CD11chigh, MHC-II high, B220 negative and Ly6G negative cells.
Detection was performed using secondary Ab, goat anti-rat-FITC
or Chicken-anti-goat-Alexa Flour 647 from Jackson Immuno
Research Laboratories, Molecular Probes and Invitrogen respec-
tively. Intracellular staining of IFNc in CD4+ T cells was
performed by re-stimulating lung lymphocytes with 1 mM of
Influenza virus nucleoprotein MHC-II restricted peptide (311–
325, QVYSLIRPNENPAHK) overnight in the presence of
brefeldin A (Sigma). Cells were stained for surface markers and
fixed with fixation/permeabilization buffer (BD biosciences) before
staining for intracellular IFNc. For enumerating virus specific
CD8+ T cells, enriched lymphocytes from the lungs were stained
with PE labelled H-2Db tetramer with the NP 366–374 epitope
ASNENMETM (Immudex) for 15 min at room temperature
followed by staining with the following antibodies: CD3e-APC and
CD8 PE-Cy7. For C3aR or C5aR staining, cells were incubated
with primary Ab for 30 min, followed by secondary Ab for
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30 min. All Ab staining was performed at 4uC. Fc blocking Ab
(Anti-Mouse CD16/CD32) was used during all FACS staining.
Flow cytometric analysis was performed using BD FACS Canto or
BD LSR II and analyzed using FlowJo software (Tree Star, San
Carlos, CA). Cell sorting of lung and dLN DCs was performed
using MoFlo (Beckman Coulter) and BD FACS Aria.
Measurement of C3a and C5a in BAL fluid by ELISA
C3a and C5a levels in bronchioalveolar lavage fluid were
quantified by a sandwich ELISA as described below. MaxiSorp
immuno modules (NUNC) were coated with 100 ml rat anti-mouse
C3a or C5a capture antibody (BD pharmingen) at 1 or 2 mg/ml in
carbonate buffer pH 9.6 or phosphate buffer pH6.5 (as recom-
mended by the manufacturer) respectively and incubated over-
night at 4uC. The plates were then washed three times with wash
buffer (PBS with 0.05% v/v Tween 20) and blocked with 200 ml
blocking buffer (PBS with 10% FBS), following which the plates
were washed 3 times before the addition of 100 ml standards or 1/
50–250 diluted BAL fluid and incubated for 2 hours at room
temperature (RT). The plates were washed again, and then 100 ml
of biotinylated rat-anti mouse C3a or C5a detecting Ab (BD
pharmingen) was added at 2 mg/ml concentration to each well
(RT, 1 hour). After washing, 100 ml of horseradish peroxidase
(HRP) conjugated streptavidin at 1 mg/ml (Jackson Immuno
research laboratories) was added and incubated for 30 minutes at
RT. Subsequently, the plates were washed and 100 ml TMB
substrate solution (Pierce Biotechnology Inc) was added to each
well, and incubated in the dark (RT, 30 min). The reaction was
stopped with the addition of 50 ml stop solution (2N H2SO4) to
each well. The absorbance was read at 450 nm; reference
wavelength 570 nm (Tecan GENios/Magellan). C3a or C5a
levels were expressed as ng/100 mg of BAL fluid protein. Total
protein in the BAL fluid was quantified by Bradford method (Bio-
Rad) following manufacturer’s instructions.
Analysis of T cell proliferation in vivo and ex vivo
CD4+ T cells (from OT-II mice) and CD8+ T cells (from OT-I
mice) were enriched using MACS beads (Miltenyi Biotec) from
spleen and lymph node single cell suspension. Enriched cells were
labelled with 5 mM of CFSE violet (Molecular Probes, Invitrogen)
following manufacturer’s instructions. Approximately 26106
CD8+ T cells or 56106 CD4+ T cells in 200 ml volume were
injected retro-orbitally followed by intranasal flu infection. dLN
were harvested on day 3 and T cell proliferation was determined
by CFSE dilution. For ex vivo analysis mDC subsets were sorted
from the dLN of OT-I PR8 infected mice and co-cultured in U
bottomed plates at a 1:10 ratio with CFSE labelled OT-I CD8+ T
cells for 3 days. T cell divisions were measured by flow cytometry.
The division index was calculated using Flow Jo software.
DC migration studies
Influenza infected mice were intranasally instilled with 25 ml
8 mM CFSE (Molecular Probes, Invitrogen) for labelling lung DC
in vivo at indicated time points. Mice were sacrificed 16 hours later
and the dLN were removed and analysed for DCs. In some
experiments, mice were treated intraperitoneally with either C3aR
antagonist - N2-[(2,2-Diphenylethoxy) acetyl]-L-arginine
(SB290157, Calbiochem) at 500 mg/mouse or C5aR antagonist-
cyclic hexapeptide AcF[OPdChaWR] at 1 mg of peptide/g of
mouse weight or both together. Compstatin at a concentration of
1 mg of peptide/g of mouse weight was used as the control.
Treatment was started 2 days before influenza infection and
continued daily until the mice were sacrificed. In some experi-
ments CD11c+ DCs were purified from the pooled lungs of
influenza infected mice, CFSE labeled and then administered into
the lungs of influenza infected mice. The migration of recipient
mDCs in the donor mice were analysed in the dLN 18 hours after
adoptive transfer.
Reverse transcription of mRNA, RT-PCR, and primers
Total RNA was obtained from lung tissue/sorted DC popula-
tion using the RNeasy kit (Qiagen), following which cDNA was
then obtained using QuantiTect Reverse Transcription kit
(Qiagen). Both kits were used as per manufacturer’s protocol.
Real-time PCR was performed on an ABI7500 real time PCR
system using SYBR Green (Applied Biosystems) Primers used for
qRT-PCR are as follows: Influenza M-protein-forward: 59-GGA
CTG CAG CGT TAG ACG CTT-39 and reverse: 59-CAT CCT
GTT GTA TAT GAG GCC CAT-39; C3-forward: 59-AAG CAT
CAA CAC ACC CAA CA-39 and reverse: 59- CTT GAG CTC
CAT TCG TGA CA-39; C5-forward: 59-GCA TTT CTG ACA
CCA GGC TTC-39 and reverse: 59- AGC GCA CAG TCA GCT
TCC A-39; C3aR-forward: 59-TGA AAG CAG GGA GTG TTG
AG-39 and reverse: 59-TGC TCA CTT GCT CAC ATG AA-39;
C5aR-forward: 59- CCA TGG ACG ACT CCT AAG GT-39 and
reverse: 59-CTC CTC TAC ACC GCC TGA CT-39
Statistical analysis
Data were analyzed using Prism GraphPad software. Statistical
significance was determined by one-way ANOVA or the unpaired
Student t test.
Supporting Information
Figure S1 C32/2 mice show decreased effector T cell
response and viral clearance upon infection with
influenza. WT and C32/2 mice were infected with flu and on
day 7 post infection the flu specific CD4+ and CD8+ T cell
response were evaluated. (A) Graph shows the frequency of IFNc
secreting CD4+ T cells in lungs by ex vivo overnight stimulation
with MHC-II flu peptide on day 7 post infection. (B) Bar graph
shows the absolute numbers of IFNc secreting CD4+ T cells in
lungs on day 7 post infection (C) Graph shows the frequency of Flu
specific CTL response in lung as measured by Flu peptide
(ASNENMETM (NP 366–374)/H-2D
b tetramer staining on day 7
post infection. (D) Bar graph shows the absolute numbers of flu
specific CD8+ T cells in lungs by tetramer staining on day 7 post
infection.(E) Graph shows the relative mRNA expression level of
influenza M protein in lung tissues of WT and C32/2 mice at the
indicated days after influenza infection.
(PDF)
Figure S2 Characterization of dLN mDC subsets. Dot
plots show the flow cytometric analysis of dLN mDC subsets and
resident CD8a DCs in naı¨ve WT and C32/2 mice. Gate III
(resident DCs) and IV (mDCs) were selected on the basis of
CD11chi MHC IIhi expression. Gate IV were subsequently divided
on the basis of CD103 (gate V) and CD11b (gate VI) expression.
Gate III were subsequently gated for CD8a DCs (gateVII) on the
basis CD8a and CD11b expression
(PDF)
Figure S3 Characterization of lung mDC subsets. Dot
plots show the flow cytometric analysis of lung DC subsets in
naı¨ve WT and C32/2 mice. Autofluorescent cells were
excluded from the analysis (gate III) and subsequently
plasmacytoid DCs (pDCs) and Gr-1+ cells were gated out on
the basis of B220 and Ly6C expression (gate IV) respectively.
The remaining DCs were defined as CD11c+ MHC-II+ (gate
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V) which were further divided on the basis of the expression of
CD103 (gate VI) and CD11b (gate VII).
(PDF)
Figure S4 A. Flow cytometric analysis for the expres-
sion of langerin-EGFP on lung DCs and other lineage
cells in langerin-DTR mouse. Single cell preparations from
the lungs of WT and langerin-DTR were gated for live cells
(DAPI-ve) and CD45+ve cells and then analyzed for indicated
lineage markers. Expression of langerin was analyzed through the
expression of GFP (langerin-DTR mice expresses GFP under the
control of langerin) on the indicated cell types. Histograms shows
the expression of langerin-GFP in the depicted populations. Grey :
WT, Open: langerin-DTR mice) B. Flow cytometry data to
show specific depletion of CD103+ DCs in the lungs of
langerin-DTR mice. WT and langerin-DTR mice were either
treated with DT or not and the number of CD103+ and CD11b+
DCs in the lungs were evaluated by flow cytometry after 48 hours
after DT administration.. Numbers indicate the number of cells
within each gate.
(PDF)
Figure S5 Diphtheria toxin (DT) does not show any
toxicity during influenza infection. (A) Percentage of body
weight loss after influenza infection. A weight loss of ,20% and
recovery represents a sub-lethal infection. (B) Survival curve
comparing influenza infected +/2 DT. (n = 6–7 in each group).
(PDF)
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